Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

High-Throughput Molecular Profiling of Multiple Myeloma (MM) Clonotypic CD19+ B Cells Highlights Pathways Potentially Involved in the Disease Endurance

Marina Martello, PhD, Angela Flores Dico, Daniel Remondini, PhD, Giovanni Martinelli, MD, Enrica Borsi, PhD, Barbara Santacroce, Lucia Pantani, MD, Elena Zamagni, MD, Paola Tacchetti, MD, Annamaria Brioli, MD, Anna Beatrice Zannetti, MD, Katia Mancuso, MD, Serena Rocchi, MD, Annalisa Pezzi, Statistician, Nicoletta Testoni, PhD, Giulia Marzocchi, PhD, Gaia Ameli, Michele Cavo, MD, Carolina Terragna, PhD

Blood (2014) 124 (21): 2054.

https://doi.org/10.1182/blood.V124.21.2054.2054

Published: 2014

Journal Articles

Five-Year Outcome of 215 Newly Diagnosed Chronic Myeloid Leukemia Patients Treated Frontline with Nilotinib-Based Regimens: A Gimema CML Working Party Analysis

Blood (2014) 124 (21): 3141.

https://doi.org/10.1182/blood.V124.21.3141.3141

Published: 2014

Journal Articles

Next-Generation Sequencing Analysis Revealed That BCL11B Chromosomal Translocation Cooperates with Point Mutations in the Pathogenesis of Acute Myeloid Leukemia

Blood (2014) 124 (21): 2352.

https://doi.org/10.1182/blood.V124.21.2352.2352

Published: 2014

Journal Articles

Ultra-Deep Sequencing Strategy Is a Precious Tool to Find Small Clones Harbouring FLT3 Mutations in AML Patients

Elisa Zuffa, PhD, Eugenia Franchini, Cristina Papayannidis, MD PhD, Carmen Baldazzi, PhD, Nicoletta Testoni, PhD, Federica Cattina, MD PhD, Maria Chiara Abbenante, Stefania Paolini, Ilaria Iacobucci, PhD, Viviana Guadagnuolo, Antonella Padella, Giorgia Simonetti, PhD, Emanuela Ottaviani, Giovanni Martinelli, MD

Blood (2014) 124 (21): 1040.

https://doi.org/10.1182/blood.V124.21.1040.1040

Published: 2014

Journal Articles

Long Term Follow up on Patients with Ph-Abnormal Clones Emerged during Imatinib Therapy.

Elisabetta Abruzzese, MD, Alessandro Gozzetti, MD, Nicoletta Testoni, PhD, Alfonso Zaccaria, MD, Franca Radaelli, MD, Sara Galimberti, MD, Malgorzata M. Trawinska, MD, Marco Mancini, MD, Dario Ferrero, MD, Michela Salvio, MD, Federica Sora’, MD, Monica Crugnola, MD, Michele Cedrone, MD, Gianantonio Rosti, MD, Sergio Amadori, MD, Paolo de Fabritiis, MD, Michele Baccarani, MD

Blood (2006) 108 (11): 2116.

https://doi.org/10.1182/blood.V108.11.2116.2116

Published: 2006

Journal Articles

Superior Complete Remission/Very Good Partial Remission Rate with Peri-Transplant Administration of Thalidomide-Dexamethasone for Newly Diagnosed Multiple Myeloma.

Michele Cavo, MD, Elena Zamagni, MD, Patrizia Tosi, MD, Delia Cangini, MD, Paola Tacchetti, MD, Claudia Cellini, MD, Nicoletta Testoni, PhD, Chiara Nicci, PhD, Antonio de Vivo, MD, Giulia Perrone, MD, Michela Ceccolini, MD, Michele Baccarani, MD

Blood (2005) 106 (11): 5474.

https://doi.org/10.1182/blood.V106.11.5474.5474

Published: 2005

NARROW

High-Throughput Molecular Profiling of Multiple Myeloma (MM) Clonotypic CD19+ B Cells Highlights Pathways Potentially Involved in the Disease Endurance

Five-Year Outcome of 215 Newly Diagnosed Chronic Myeloid Leukemia Patients Treated Frontline with Nilotinib-Based Regimens: A Gimema CML Working Party Analysis

Next-Generation Sequencing Analysis Revealed That BCL11B Chromosomal Translocation Cooperates with Point Mutations in the Pathogenesis of Acute Myeloid Leukemia

Ultra-Deep Sequencing Strategy Is a Precious Tool to Find Small Clones Harbouring FLT3 Mutations in AML Patients

Long Term Follow up on Patients with Ph-Abnormal Clones Emerged during Imatinib Therapy.

Superior Complete Remission/Very Good Partial Remission Rate with Peri-Transplant Administration of Thalidomide-Dexamethasone for Newly Diagnosed Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

High-Throughput Molecular Profiling of Multiple Myeloma (MM) Clonotypic CD19+ B Cells Highlights Pathways Potentially Involved in the Disease Endurance

Five-Year Outcome of 215 Newly Diagnosed Chronic Myeloid Leukemia Patients Treated Frontline with Nilotinib-Based Regimens: A Gimema CML Working Party Analysis

Next-Generation Sequencing Analysis Revealed That BCL11B Chromosomal Translocation Cooperates with Point Mutations in the Pathogenesis of Acute Myeloid Leukemia

Ultra-Deep Sequencing Strategy Is a Precious Tool to Find Small Clones Harbouring FLT3 Mutations in AML Patients

Long Term Follow up on Patients with Ph-Abnormal Clones Emerged during Imatinib Therapy.

Superior Complete Remission/Very Good Partial Remission Rate with Peri-Transplant Administration of Thalidomide-Dexamethasone for Newly Diagnosed Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only